-
Thu01Oct2026Sat03Oct2026
-
Sat03Oct2026Sun04Oct2026
-
Sun04Oct2026Wed07Oct2026
-
Tue06Oct2026Fri09Oct2026
-
Wed14Oct2026Fri16Oct2026Santiago de Compostela, Spain
-
Tue17Nov2026Sat21Nov2026
-
Wed25Nov2026Fri27Nov2026
-
Thu03Dec2026Sat05Dec2026
Latest News
Humacyte announces US FDA authorisation extending Symvess shelf life to 36...
Humacyte recently announced that the US Food and Drug Administration (FDA) has authorised an extension of the expiration dating period for Symvess (acellular tissue...
Features
Out of my lane: putting PAD in the picture
Rachael Forsythe (Edinburgh, UK) provides an update from the Circulation Foundation—the UK’s only national charity dedicated to vascular disease.
Sitting in the swealtering heat on...
European aXess data: a step forward in an evolving field
Considering the impact of the latest data on a biosynthetic graft for haemodialysis, Bart Dolmatch (Palo Alto, USA) is optimistic but keen to see...
Videos
Jayer Chung (Baylor College of Medicine, Houston, USA) digs into new data showing similar outcomes between open- and endovascular-first revascularisation treatment strategies for acute...
